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ABSTRACT
Quinolone(s) (QNs) is widely used in infection therapy due to its
good antimicrobial characteristics. However, QNs-induced ar-
thropathy of immature animals has led to restrictions on the
therapeutic use of these antimicrobial agents. The exact mech-
anism(s) of QNs-induced chondrotoxicity remain unknown. In
the present study, we investigated the possible mechanism of
ofloxacin (one typical QNs)-induced injuries of chondrocytes.
Juvenile rabbit joint chondrocytes cultured in alginate micro-
spheres were incubated with ofloxacin at concentrations of 0,
2, 5, 10, 20, and 40 g/ml for up to 96 h. Concentration of 10
g/ml ofloxacin induced apoptosis of chondrocyte with visible
apoptotic signs, including degradation of poly(ADP-ribose)
polymerase, caspase-3 activation, and DNA ladder formation.
Furthermore, extracellular signal-regulated kinase 1/2 (phos-
pho-ERK1/2) and growth factor receptor-bound protein 2
(Grb2) were significantly reduced, and similar changes were
also observed in the 1-integrin receptor as assessed by im-
munoblotting. However, the mRNA level of 1-integrin obtained
from reverse transcription-polymerase chain reaction remained
unchanged. Results of 1-integrin immunoprecipitation have
also shown that 1-integrin did not interact with activated in-
tracellular signaling proteins. In addition, ofloxacin did not in-
duce apoptosis and decrease 1-integrin expression in chon-
drocytes supplemented with Mg2, and the ofloxacin-induced
apoptosis was caspase-8-dependent, inhibition of which did
not affect the expression mode of phospho-ERK1/2 and 1-
integrin. Our results demonstrate that ofloxacin affects 1-
integrin receptor functions and the ERK mitogen-activated pro-
tein kinase signaling pathway, causing caspase-8-dependent
apoptosis after exposure of 48 h.
QNs and their fluoro derivatives, such as ofloxacin or cip-
rofloxacin, are widely used antimicrobial agents for their
broad spectrum activity and favorable pharmacokinetics
(Neu, 1992). However, their neurotoxicity, phototoxicity, car-
diotoxicity, hepatotoxicity, and chondrotoxicity, the severity
of which differs among the individual drugs of this class,
have led to severe restrictions in their use and even to the
withdrawal of some QNs from the market. Among the toxic-
ities of QNs, one major disadvantage is their chondrotoxicity
potential in juvenile animals, such as rats (Kato and On-
odera, 1988), dogs (Burkhardt et al., 1992), rabbits (Machida
et al., 1990), nonhuman primates (Stahlmann et al., 1990),
and others (Gough et al., 1992). This toxicity is manifest as
lameness, blistering, ulcerative erosion, or cavitation of the
articular cartilage of the weight-bearing joints and chondro-
cyte loss and matrix degeneration (Gough et al., 1979; Kato
and Onodera, 1988). Dosage needed to induce cartilage dam-
age in juvenile dogs falls in the therapeutic range. Therefore,
these drugs are contraindicated in pediatric patients (Stahl-
mann and Lode 2000). It is still controversial whether pedi-
atric patients are at risk of arthropathy and under what
circumstances therapy with QNs might be appropriate in
children (Schaad and Wedgwood, 1992; Schaad, 1993).
Therefore, a thorough evaluation of the risk would be much
more reliable if additional information on the mechanism of
the QNs-induced arthropathy was available.
However, the exact mechanism of QNs-induced arthropa-
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thy is still unknown. Recently, a number of studies have
demonstrated that QNs-induced arthropathy is possibly due
to the magnesium-chelating properties of QNs (Stahlmann et
al., 1995; Shakibaei et al., 1996; Vormann et al., 1997). QNs
are metal chelators (Lomaestro and Bailie, 1991), and one
possible consequence of the chelation of Mg2 can be an effect
on integrin, the binding of which to their ligands is a cation-
dependent process (Dickeson et al., 1997). Integrins are im-
portant surface molecules on chondrocytes and transmit
signals in both directions across the plasma membrane
(Akiyama, 1996), thus regulating cell adhesion, proliferation,
differentiation, and proteoglycan synthesis.
The interaction between chondrocytes and matrix proteins
is mediated largely by the 1 subfamily of integrins (Dürr et
al., 1993; Woods et al., 1994). Therefore, QNs appear to
disturb the normal functioning of signaling proteins like
1-integrin and, subsequently, their essential regulation of
cell-cell and cell-matrix interactions.
The activation of specific intracellular signaling proteins,
due to interactions between matrix proteins and integrins,
has been studied in various cell types. Shakibaei et al. (2001)
demonstrated that MAPK signaling pathway has regulatory
functions on differentiation and survival of chondrocytes and
that inhibition of this pathway can induce apoptosis of hu-
man chondrocytes. Recently, Sendzik et al. (2005) have
shown that changes in 1-integrin receptor protein and its
downstream signaling proteins (such as phospho-ERK1/2)
result in apoptosis of tenocytes, which is considered as the
final event in QNs-induced tendopathies. Parallels might
exist in the mechanisms of chondrotoxicity and tendotoxicity
of QNs, because tendon and cartilage have marked organi-
zational similarities; both are characterized by a low vascu-
larization (bradytrophia tissue) and similar matrix compo-
nents, transmembrane and intracellular signaling proteins.
The observations mentioned above led us to believe that
disturbance of 1-integrin receptor functions, subsequently
inactivating the ERK/MAPK signaling pathway, might in-
duce chondrocyte apoptosis. In addition, there is no report so
far showing the involvement of apoptosis in QNs-induced
joint cartilage injury. Therefore, the aim of the present study
was to investigate whether QNs induce chondrocyte apopto-
sis and the possible role of 1-integrin receptors in the
process.
Because signaling events associated with 1-integrin seem
to take place only inside the three-dimensional (3-D) collagen
matrix, rather than in monolayer cultures (Heino, 2000), a
3-D cell culture system with chondrocytes microencapsulated
in alginate microspheres was employed as an experiment
model.
Materials and Methods
Materials. All chemicals (ofloxacin: CAS 82419-36-1;
C18H20FN3O4) were of reagent grade or better and were purchased
from Sigma Chemical Co. (St. Louis, MO) unless otherwise noted.
Sodium alginate (type -hydroxybutyrate) was obtained from Kelco
(Waterfield, UK). Acridine orange (AO, 10 mg/ml) and ethidium
bromide (EB, 10 mg/ml) were purchased from Invitrogen (Carlsbad,
CA), and further dilutions were made in 0.9% normal saline before
use. The caspase-3 inhibitor z-DEVD-fmk was purchased from MBL
International (Woburn, MA) as sterile solution (2 mM). RNA isola-
tion kits, Gene-Amp RNA PCR kit, and GAPDH primers were from
Invitrogen. The primary rabbit monoclonal antibody against 1-in-
tegrin was purchased from BOSTER (Wuhan, China), and mouse
monoclonal antibodies against uncleaved (116 kDa) and cleaved (85
kDa) PARP, caspase-3, type I collagen, type II collagen, Grb2, total-
ERK1/2, and phospho-ERK1/2 were from Cell Signaling (Beverly,
MA). Polyclonal antibody against the 1-cytoplasmic domain was
provided by our laboratory. Goat anti-mouse or anti-rabbit IgG con-
jugated with horseradish peroxidase was from BOSTER. Suicide
Track DNA Ladder Isolation Kit (AM41-1EA) was from EMD Bio-
sciences (San Diego, CA).
Cell Culture and Microencapsulation. All tissue manipula-
tions were carried out under sterile, aseptic conditions. Juvenile New
Zealand White rabbit (21-day-old) joint cartilage segments were
excised from both humeral and femoral heads and placed in Dulbec-
co’s modified Eagle’s medium (DMEM) solution containing 200 g/ml
gentamycin and 0.5 g/ml amphotericin immediately after surgery.
The perichondrium was removed to prevent contamination with
fibroblasts, and minced cartilage particles (1 mm3) were digested
with 0.15% collagenase II solution in fresh DMEM at 37°C for 8 to
12 h. The resulting suspension was centrifuged at 400g for 10 min,
and the chondrocyte pellets were resuspended in DMEM with 146
g/ml L-glutamine, 50 g/ml gentamycin, and 10% fetal bovine se-
rum. Chondrocytes were plated on 75-cm2 vented polystyrene cell
culture flasks and incubated in a humidified incubator at 37°C with
5% CO2. The culture medium was changed twice a week. Cells were
trypsinized using trypsin/EDTA solution (0.05/0.02%) for 2 to 5 min
at 37°C and serially passaged after reaching confluence.
One volume of chondrocytes suspension (2.5  106 ml1 viable
cells) was mixed gently with one volume of sodium-alginate solution
[alginate 0.5–3% (w/v) in PBS] to give a cell density of 1.25  106
ml1 viable cells in 0.25 to 1.5% -hydroxybutyrate alginate as
shown under Results. An air jet pellator was used to produce micro-
drops of a defined diameter (400–500 m) using a flow rate of 62 ml
h1and a pressure of 190  10 mbar. The alginate microdrops were
collected in a polymerization buffer [620 ml of glucose solution, 100
ml of HEPES-buffer (250 mM HEPES adjusted to pH 7.6 with
NaOH), 100 ml of salt solution (1 M NaCl, 23 mM KCl, and 1 M
CaCl22H2O), 150 ml of amino acid solution, 10 ml of glutamine
solution, 5 ml of insulin solution, and 2 g/ml bovine serum albumin]
for microencapsulation. During microencapsulation, the polymeriza-
tion buffer was constantly stirred. The resulting beads were removed
from the polymerization buffer and washed with PBS. Thereafter,
the beads were transferred to the cell culture medium.
Microencapsulated chondrocyte beads were placed in 14.5-cm tis-
sue culture dishes at a density of 1.5  107 cells per dish in 30 ml of
culture medium consisting of William’s medium E supplemented
with 10% fetal bovine serum, 7 M insulin (I-6634; 28.5 IU mg1
insulin), 100 nM dexamethasone, 4 mM L-glutamine, and 1% peni-
cillin/streptomycin solution. After 3 h, the culture medium was re-
placed by 30 ml of fresh medium.
Ofloxacin Treatment. After 24 h of culture, the medium was
renewed. The microencapsulated chondrocytes were exposed to
ofloxacin at 0 to 40 g/ml for up to 96 h. To make ofloxacin solutions
achieve optimal solubility and final pH at 7.2, ofloxacin was predi-
luted in a NaOH solution (0.1 N), followed by dilution in PBS solu-
tion at pH 5 to 6. The cells were cultured in a humidified incubator
(5% CO2) at 37.5°C. Care was taken to distribute the beads evenly on
the plate through the duration of the experiment.
Harvesting of Ofloxacin-Treated Microencapsulated Chon-
drocytes. After incubation with ofloxacin, the beads were trans-
ferred to 50-ml tubes on ice. Two volumes of sodium citrate buffer (10
mM trisodium citrate in PBS, pH 7.4, at 4°C) were added to one
volume of beads. The beads were gently shaken and dissolved within
2 min. Three volumes of PBS (4°C) were added to the cell suspension,
and the cells were harvested by centrifugation (50g, 10 min, 4°C).
The pellets were resuspended in 1 ml of PBS and homogenized by
sonication.
Cell Viability Assay and Determination of Apoptosis. Cell
viability was determined by a modified 3-(4,5-dimethyl-thiazol-2-yl)-











2,5-diphenyl-tetrazolium bromide (MTT) assay (Mosmann, 1983). At
the end of treatment, 100 l of MTT (5 mg/ml in 1 M PBS, pH 7.6)
was added to 1 ml of microencapsulation culture solution (approxi-
mately five to seven microcapsules) to each well of six-well plates and
allowed to incubate for 2 h at 37°C in 5% CO2/95% air. The MTT
solution was then removed, and 100 l of N,N-dimethylformamide
destaining solution (N,N-dimethylformamide: Triton X-100, 3:1;
w/w) was added. The plates were agitated on a plate shaker for 10
min at room temperature to thoroughly dissolve the MTT product,
and 0.2 ml was transferred to 96-well plates. The optical density
(OD) was measured using a microplate reader at 570 nm. Viability of
the cells without ofloxacin treatment was defined as 100%, and the
experiment was repeated three times.
Quantitation of apoptosis was performed using fluorescent stain-
ing as described previously (Duke and Cohen, 1992). Dual staining
allows separate enumeration of viable nonapoptotic, viable (early)
apoptotic, nonviable (late) apoptotic, and necrotic cells. Viable cells
have uniformly stained green nucleus. Viable (early) apoptotic cells
have condensed or fragmented green nuclei. All nonviable cells have
orange nuclei, because ethidium bromide staining overwhelms acri-
dine orange staining. Nonviable (late) apoptotic cells have orange-
fragmented nuclei, whereas necrotic cells have uniformly stained
nonfragmented orange nuclei. Cells were pelleted, resuspended in 50
l of DMEM, and stained with 4 l of AO-EB working solution (100
g/ml of acridine orange and 100 g/ml of ethidium bromide in 0.9%
saline). Samples were immediately analyzed by fluorescence micros-
copy utilizing the fluorescein filter (excitation at 488 nm, emission at
520 nm). A minimum of 180 cells was counted in multiple, randomly
selected fields from each sample. Results were expressed as mean
percentage of apoptosis in different fields  S.D.
Measurement of Proteoglycan Content. Proteoglycan (PG)
content was assessed by 1,9-dimethylmethylene blue assay (DMB;
Polysciences, Warrington, PA). Chondrocyte/alginate beads/cartilage
explants were harvested and dissolved, and the two compartments
[cell-associated matrix and further removed matrix] were separated
by centrifugation at 100g for 10 min at 4°C. Each fraction was
digested with papain (concentration of papain: cell-associated ma-
trix, 20 mg/ml; further removed matrix, 40 mg/ml) at 55°C for 18 h.
The digested samples (75 l) were mixed with 25 l of 2.88 M GuHCl
solution and 200 l of DMB reagent in a 96-well plate, and absor-
bance was immediately measured at 590 nm by a plate reader
(SPECTRA MAX250; Molecular Devices, Sunnyvale, CA). PG con-
tent was determined using a chondroitin-6-sulfate standard curve
(0–100 g/ml). DNA content was determined by the Hoechst 33258
DNA binding assay (Kim et al., 1988). Total amount of PG per well
was normalized against the total amount of DNA per well.
Analysis of DNA Fragmentation by Agarose Gel Electro-
phoresis. Genomic DNA was prepared from 5  106 cells and
electrophoresed through a 1.5% agarose gel. Oligonucleosomal apo-
ptotic DNA fragments ladder separated on the gels were visualized
after EB staining, and photodocumentation was performed using a
Fluorichem 8000 fluorimager (Alpha Innotech, San Leandro, CA).
RNA Extraction and RT-PCR. In brief, total RNA in chondro-
cytes was obtained using a RNA isolation kit (Invitrogen). Cells were
washed with sterile PBS and then mixed into 6 ml of a denaturing
solution. The solution was transferred to RNase-free centrifuge
tubes before sodium acetate was added to a final concentration of
0.2 M. A phenol-chloroform extraction was performed followed by
isopropanol precipitation using a routine method (Sambrook et al.,
1989). A second RNA extraction with 600 l of denaturing solution
was performed on each RNA pellet followed by a second isopropanol
precipitation. The RNA pellets were washed with 75% ethanol and
dissolved in 20 l of RNase-free water. The RNA concentration and
purity were calculated from the reading at OD260 and OD280, as
described previously (Sambrook et al., 1989). Aliquots of 10 and 20
g of RNA with an OD260:OD280 ratio 1.8 were stored in ethanol at
70°C until use.
The mRNA in 0.5 g of total RNA was transcribed to cDNA using
a Gene-Amp RNA PCR kit (Invitrogen). The final concentrations of
reagents for reverse transcription in 1 PCR buffer II were 5 mM
MgCl2, 1 mM of each nucleotide, 1 U/l RNase inhibitor, 2.5 U/l
reverse transcriptase, and 2.5 M random hexamers. The reverse
transcription reaction was carried out for 10 min at room tempera-
ture followed by 45 min at 42°C. After reverse transcription, 10 l of
each sample was removed for PCR amplification in PCR buffer II
containing 2 mM MgCl2, 2.5 U/100 l Taq polymerase, and 0.3 M of
each 1-oligonucleotide primer. The 1 primers were selected from
regions highly conserved between human and rabbit 1-integrin. The
1-integrin primers used were 5-GACCTGCCTTGGTGTCTGTG-
C-3 and 5-AGCAACCACACCAGCTACAAT-3; after incubation for
4 min at 95°C, the samples were amplified for 32 cycles at 95°C for
1 min, 54°C for 1 min, and 72°C for 3 min. A final 7-min extension at
60°C was performed after the 32 cycles. GAPDH primers were 5-C-
GTCTTCACCACCATGGAGA-3 and 5-CGGCCATCACGCCACAG-
TTT-3. Amplification of control primers for GAPDH was carried out
as recommended by the supplier, with a final concentration of 0.4 M
of each primer and temperature cycles of 95°C for 1 min and 60°C for
1 min for 32 cycles followed by a final 7-min extension at 60°C.
Amplified sequences were analyzed on 1.6% agarose-ethidium bro-
mide gels. Ratios of all experimental bands to GAPDH were used to
measure changes in mRNA expression among the different treat-
ment groups.
Immunoprecipitation and Western Blot Analysis. A detailed
description of the technique used for the following experiments has
been published previously (Shakibaei et al., 1999). In brief, chondro-
cytes were harvested from alginate cultures and then plated on
dishes coated with collagen type II, poly-L-lysine, and anti-integrin
1 and then treated with 10 g/ml ofloxacin for 48 h or left untreated.
After rinsing with PBS, treated and untreated cells were extracted
with lysis buffer containing 50 mM Tris-HCl, pH 7.2, 150 mM NaCl,
1% (v/v) Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium
pyrophosphate, 100 mM sodium fluoride, 0.01% (v/v) aprotinin, 4
g/ml pepstatin A, 10 g/ml leupeptin, and 1 mM phenylmethyl
sulfonylfluoride on ice for 30 min. For immunoprecipitation, samples
were incubated with primary antibody for the target protein (or IgG
control antibody) for 1 to 3 h at 4°C and then precipitated by incu-
bating with protein A/G-agarose overnight. Pellets were washed once
in lysis buffer followed by three washes in wash buffer consisting of
50 mM Tris-HCl, pH 7.5, 500 mM NaCl, and 0.2% Igepal CA-630 and
then three washes in wash buffer containing 10 mM Tris-HCl, pH
7.5, and 0.2% Igepal CA-630. Immunoprecipitated proteins were
analyzed by Western blot. For Western blot analysis, after adjust-
ment to a similar total protein concentration, samples were sepa-
rated by SDS-polyacrylamide gel electrophoresis (5, 7.5, 10, or 12%
gels) under reducing conditions and then transferred onto nitrocel-
lulose membranes. Membranes were preincubated in blocking buffer
[5% (w/v) skim milk powder in PBS and 0.1% Tween 20] for 30 min
before incubation with primary antibodies for 2 h at room tempera-
ture. The membranes then were washed three times in Tris-buffered
saline plus Tween 20 to remove unbounded antibodies and then
incubated with horseradish peroxidase-conjugated secondary anti-
body in 3% Tris-buffered saline plus Tween 20for 30 min at 37°C.
The immunoreactive bands were visualized using the enhanced
chemiluminescence reagents (GE Healthcare, Little Chalfont, Buck-
inghamshire, UK) according to manufacturer’s protocol and were
quantitated by densitometric scanning of X-ray films and analyzed
using Quantity One 4.1.1 software (Bio-Rad, Hercules, CA). Differ-
ences and changes in protein expression were determined relative to
the internal control GAPDH. GAPDH levels were determined for
each condition to verify that equal amounts of protein were loaded in
different lanes. In addition, the density of each protein band was
normalized to GAPDH to correct for small differences in protein
loading among the lanes.
Statistical Analysis. The results of immunoblotting were ex-
pressed as the arithmetic means  S.D. of a representative experi-
ment performed in triplicate. The means were compared using











ANOVA followed by a post hoc Dunnett’s t test assuming equal
variances; p  0.05 was considered statistically significant. This
statistical analysis was performed with treated and control samples
after 96 h of incubation only.
Results
Morphological Differences in Chondrocytes Cul-
tured in Monolayer and 3-D Microcapsules. Chondro-
cytes in hyaline cartilage can be identified by a spherical
shape in an abundant extracellular matrix. They were re-
sponsible for the synthesis, maintenance, and maturation of
the matrix within which they were embedded. Figure 1 de-
picts the representative morphology of chondrocytes cultured
in monolayer and 3-D microcapsules after 96 h of culture.
Differences in cell morphology were evident between the two
types of chondrocyte culture (Fig. 1, A and B). The monolayer
cultures produced fibroblast-like chondrocytes exhibiting a
flat, elongated morphology, expressed elevated levels of type
I collagen, and reduced levels of type II collagen and proteo-
glycan (Fig. 1, A, C, and D). Microencapsulated chondrocytes
maintained round shape and expressed high levels of extra-
cellular matrix molecules: type II collagen and proteoglycan
and low levels of type I collagen (Fig. 1, B, C, and D). Expres-
sion of type II collagen and proteoglycan in microencapsu-
lated chondrocytes was more similar to that in cartilage
explant compared with monolayer chondrocytes (Fig. 1, C
and D).
The Effect of Ofloxacin on Chondrocyte Viability
Cultured in Monolayer and 3-D Microcapsules. Chon-
drocytes cultured in monolayer and microcapsules were ex-
posed to ofloxacin in a range of concentrations (0–40 g/ml)
for different times (12–96 h), and the effect of ofloxacin on cell
viability was investigated by MTT assay. In both types of
chondrocyte cultures, ofloxacin caused a decrease in cell vi-
ability in a concentration- and time-dependent manner (Fig.
2, A and B). However, joint chondrocytes cultured in micro-
capsules were more sensitive to ofloxacin than those in mono-
layer (Fig. 2B). Loss of viability of chondrocyte cultured in
microcapsules began to be more evident compared with
monolayer after treatment with 2, 5, 10, 20, and 40 g/ml
ofloxacin at 24 h, which was decreased by 12.9, 14.2, 24.2,
31.9, and 33.6%, respectively (Fig. 2B). At 10 g/ml ofloxacin,
near the human plasma concentration, exposure for 12 to
96 h decreased the microencapsulated chondrocytes viability
Fig. 1. Morphological and functional difference between chondrocytes
cultured for 96 h in monolayer and 3-D microcapsules. Rabbit joint
chondrocytes in monolayer (A) and cultured in alginate microcapsules (B)
in brightfield microscopy. Expression of type I collagen and type II colla-
gen is determined by Western blot analysis (C), and content of proteogly-
can is determined by DMB assay (D), as described under Materials and
Methods. The results of three experiments are shown as mean  S.D.
Fig. 2. Differential effects (C) of ofloxacin on cell viability of rabbit joint
chondrocytes cultured in monolayer (A) and alginate microcapsules (B).
Cells were exposed to 0, 2, 5, 10, 20, and 40 g/ml ofloxacin and incubated
for up to 96 h. Live (viable) cells were determined by MTT assay, as
described under Materials and Methods. The results of three experiments
are shown as mean  S.D. , p  0.05 versus 2-D culture.











significantly, compared with chondrocytes cultured in mono-
layer (Fig. 2C).
Ofloxacin Induces Apoptosis in Microencapsulated
Chondrocytes. To investigate whether the ofloxacin-in-
duced loss in cell viability was due to apoptosis, microencap-
sulated chondrocytes were exposed to the increasing concen-
trations of ofloxacin for 72 and 96 h, and the fraction of dead,
apoptotic, and necrotic cells were determined (data of the
concentration 20 and 40 g/ml not shown considering the in
vivo plasma concentration of ofloxacin) (Fig. 3). As expected,
ofloxacin induced apoptosis of microencapsulated chondro-
cyte in a concentration-dependent manner. The percentage of
dead cells was significantly increased by 20.8, 40.3, and
55.6% for 72 h and 40.9, 65.8, and 84.4% for 96 h, respec-
tively, as the concentration of ofloxacin was increased from 0
to 2, 5, and 10 g/ml and was higher at 96 h compared with
72 h of exposure to ofloxacin (Fig. 3A). Analysis of the same
cell population revealed that the percentage of apoptotic cells
increased by 26.4, 41.5, and 57.7% for 72 h and 40.7, 66.7,
and 85.9% for 96 h, respectively, in correlation to the per-
centage of dead cells (Fig. 3B). The fraction of apoptotic cells
after 72 and 96 h of exposure to ofloxacin was similar to that
of dead cell under the same conditions (Fig. 3, A compared
with B). No significant increase in the percentage of necrotic
cells was observed in the exposed cells compared with control
unexposed cells under these experimental conditions (Fig.
3C). The above results shown in Fig. 3 demonstrate that
ofloxacin-induced cell death in microencapsulated chondro-
cytes was mainly due to apoptosis, rather than necrosis at
the concentration of 2, 5, and 10 g/ml after 72 and 96 h of
exposure.
To further confirm the occurrence of ofloxacin-induced
apoptosis, microencapsulated chondrocytes were incubated
with ofloxacin at 0, 5, and 10 g/ml for 96 h. PARP cleavage
and DNA fragmentation, characteristic of apoptotic cells,
then were analyzed. PARP is a zinc-finger DNA-binding pro-
tein, which catalyzes the synthesis of poly(ADP-ribose) from
its substrate -NAD and can be selectively cleaved by
caspase-3 during apoptosis (Tewari et al., 1995; Salvesen and
Dixit, 1997). Therefore, the PARP cleavage has been re-
garded as evidence of caspase activation and widely used as
a hallmark of cell apoptosis.
In the present study, the native uncleaved 116-kDa PARP
band in control, unexposed cells were increasingly cleaved to
the 85-kDa form when the cells were exposed to increasing
concentrations of ofloxacin from 5 to 10 g/ml (Fig. 4A).
Under these conditions, GAPDH levels remained unchanged
in the same samples, confirming the absence of experimental
artifacts. In addition, one important characteristic feature of
apoptosis was the fragmentation of intact DNA into internu-
cleosomal fragmentation to fragments of 180 base pairs and
multiples, resulting in a ladder in gel electrophoresis. As
Fig. 3. Ofloxacin induces apoptosis in rabbit joint chondrocytes in a
concentration- and time-dependent manner. Cells were exposed to 0, 2, 5,
and 10 g/ml ofloxacin and incubated for 72 and 96 h. The percentage of
dead (A), apoptotic (B), and necrotic (C) cells was determined by fluores-
cent staining, as described under Materials and Methods. The results of
three experiments are shown. Bars represent the mean  S.D. (, p 
0.05).
Fig. 4. PARP cleavage and DNA fragmentation are observed in rabbit
joint chondrocytes undergoing ofloxacin-induced apoptosis. Cells exposed
to 0, 5, and 10 g/ml ofloxacin for 96 h were analyzed for PARP cleavage
by Western blot (A), as described under Materials and Methods. The
native 116-kDa form and the cleaved 85-kDa form of PARP were detected
by anti-PARP antibody. GAPDH levels were determined to normalize for
the quantity of protein retained on the blot. Cells were exposed to 0, 2, 5,
and 10 g/ml ofloxacin for 96 h, and DNA fragmentation was analyzed as
described under Materials and Methods (B). Size markers (M) are shown
for demonstrating the characteristic DNA ladder.











shown in Fig. 4B, ofloxacin induced internucleosomal DNA
fragmentation, clearly exhibiting the characteristic ladder of
oligonucleosomal DNA fragments, which was not observed in
unexposed control cells. Collectively, the detection of apopto-
sis by PARP cleavage and the characteristic DNA ladder
confirm the occurrence of apoptosis in microencapsulated
chondrocytes exposed to ofloxacin.
Ofloxacin Stimulates Activation of Caspase-3.
Caspases are common apoptotic cell death executors. To de-
termine whether caspases were activated in the presence of
ofloxacin, we assessed the activation of caspase-3, known as
the final effector of apoptosis (Saraste and Pulkki, 2000), by
analyzing the processing and activation of caspase-3. Mi-
croencapsulated chondrocytes were exposed to 0 or 10 g/ml
ofloxacin for 96 h, and the activation of caspase-3 was deter-
mined by Western blot analysis. Figure 5A shows that the
level of the active enzyme complex, the p19 smaller subunit,
was significantly increased in exposed cells compared with
control unexposed cells. To further confirm whether activa-
tion of caspase-3 was involved in ofloxacin-induced apoptosis,
the effect of the caspase-3 inhibitor z-DEVD-fmk on ofloxa-
cin-induced apoptosis was investigated. Microencapsulated
chondrocytes were exposed to 0 or 10 g/ml ofloxacin for 96 h
in the presence or absence of 2 M z-DEVD-fmk, and cells
were scored for apoptosis by fluorescent staining (Fig. 5B).
z-DEVD-fmk reduced ofloxacin-induced apoptosis by approx-
imately 80%, which exhibited the same effect on apoptosis of
the control-unexposed cells. Higher concentration (5 M) of
z-DEVD-fmk was not any more effective in inhibiting ofloxa-
cin-induced apoptosis (data not shown), indicating that max-
imal inhibition of caspase-3 was achieved under these exper-
imental conditions. These results indicated that caspase-3, in
particular, was involved in ofloxacin-induced apoptosis.
Effect of Ofloxacin on 1-Integrin Function and
ERK/MAPK Signaling Pathway. To further explore
whether ofloxacin-induced apoptosis was related to 1-inte-
grin receptor and ERK/MAPK signaling pathway, which are
known to be involved in apoptosis of chondrocytes (Shakibaei
et al., 1999, 2001), Western blot analysis was used to deter-
mine the effects of ofloxacin on the expression of 1-integrin,
Grb2, and phospho-ERK1/2. Microencapsulated chondro-
cytes were incubated with 10 g/ml ofloxacin for 12, 24, 48,
72, and 96 h. RT-PCR analysis using primers for 1-integrin
revealed no significant difference (Fig. 6A). However, ofloxa-
cin caused a decrease in the receptor chain 1-integrin (117
kDa) under these experimental condition after 48 h of expo-
sure (Fig. 6B). Therefore, we further assessed the effect of
ofloxacin on 1-integrin function by coimmunoprecipitation
Fig. 5. Effect of ofloxacin on caspases-3 activation. Cells exposed to 0 or
10 g/ml ofloxacin for 96 h were prepared and analyzed for caspases-3
processing by Western blot with an anti-caspase-3 antibody, as described
under Materials and Methods. The unprocessed form of caspase-3 (pro-
caspase-3; 32 kDa) and the cleavage product (p19) of the active enzyme
are indicated (A). Cells were preincubated with 0 or 2 M caspase-3
inhibitor z-DEVD-fmk for 1 h, followed by exposure to 0 or 10 g/ml
ofloxacin for 96 h. Inhibition of ofloxacin-induced apoptosis by caspase-3
inhibitor was analyzed by fluorescent staining (B), as described under
Materials and Methods. Results from three experiments are shown; bars
represent the mean  S.D. (, p  0.05).
Fig. 6. Effects of ofloxacin on gene and protein expression of 1-integrin.
RT-PCR and Western blot results obtained with cells exposed to 10 g/ml
ofloxacin and incubated for 12, 24, 48, 72, and 96 h, as described under
Materials and Methods. The 1-integrin mRNA levels were analyzed by
RT-PCR and normalized against GAPDH (A). An antibody against 1-
chain of integrins was used for detection of the protein expression levels
by Western blot (B). The results of three experiments are shown; bars
represent the mean  S.D. , p  0.05 versus controls after 96 h of
incubation (ANOVA followed by a post hoc Dunnett’s t test).











assays. As shown in Fig. 7, the cytoplasmic domain of 1-
integrin did not interact with activated intracellular signal-
ing proteins (FAK, vinculin, paxillin, and -actinin) after
exposure of cells to 10 g/ml for 48 h. Densitometric analysis
of a representative experiment, performed in triplicate from
ofloxacin-treated chondrocytes, showed that the relative ra-
tios of paxillin, -actinin, vinculin, and FAK expression to the
1-integrin pulled down by immunoprecipitation with anti-
1-integrin antibody decreased by 94, 97, 81, and 92% com-
pared with untreated chondrocytes, respectively. In addition,
it is found that ofloxacin did not affect the occurrence of
apoptosis and 1-integrin expression of microencapsulated
chondrocytes under the condition of magnesium supplement
(Fig. 8). The signaling proteins Grb2 (23kDa) (Fig. 9A) and
phospho-ERK1/2 (44/42 kDa) (Fig. 9B) were reduced after
exposure to 10 g/ml ofloxacin for postexposure 48, 72, 96 h,
and ofloxacin also markedly decreased the level of phospho-
ERK1/2 and 1-integrin for the same time points in the
presence of specific caspase-3 inhibitor z-DEVD-fmk (Fig.
10). In addition, an inhibitor of the ERK/MAPK signaling
pathway, U0126, caused apoptosis of microencapsulated
chondrocytes in a concentration-dependent manner (Fig.
11A). However, levels of 1-integrin protein were unchanged
under the same conditions (Fig. 11B). These data suggested
that ofloxacin probably inactivated the ERK/MAPK signaling
pathway of microencapsulated chondrocytes by disturbing
the function of 1-integrin receptors.
Effect of Caspase-8-Specific Inhibitor on Ofloxacin-
Stimulated Apoptosis and 1-Integrin Expression. Stu-
pack et al. (2001) had suggested that “integrin-mediated
death” was induced by the activation of caspase-8 in a death
receptor-independent manner. Therefore, we further investi-
gated the effect of caspase-8-specific inhibitor z-IETD-fmk on
ofloxacin-induced apoptosis. Before incubation with 10 g/ml
ofloxacin for 96 h, the microencapsulated chondrocytes were
preincubated for 4 h in the presence or absence of z-IETD-
Fig. 7. Effects of ofloxacin on 1-integrin function. A, serum-starved cells
were either treated with 10 g/ml ofloxacin or left untreated for 48 h and
then immunoprecipitated (IP) with anti-1-cytoplasmic domain (1) an-
tibody and normal IgG serum control (C). Immunoprecipitates of the
indicated proteins were separated by SDS-polyacrylamide gel electro-
phoresis and probed with antibodies specific for paxillin, -actinin, vin-
culin, and FAK, as described under Materials and Methods. IgG control
antibodies were used to control for nonspecific interaction. Results shown
are a representative of three independent experiments. IgH, immuno-
globulin heavy chain. B, immunoprecipitation blots from ofloxacin-
treated and untreated chondrocytes were probed with anti-1-cytoplas-
mic domain antibody and quantified by densitometry.
Fig. 8. Effects of ofloxacin on 1-integrin expression and apoptosis in
medium supplemented with magnesium. Western blot and fluorescent
staining results were obtained with cells exposed to 10 g/ml ofloxacin
and incubated for 12, 24, 48, 72, and 96 h in medium supplemented with
97.7 g/ml magnesium, as described under Materials and Methods. An
antibody against 1-chain of integrins was used for detection of the
protein expression levels by Western blot (A). The quantitation of apo-
ptosis was analyzed by AO-EB fluorescent staining assay (B). The results
of three experiments are shown; bars represent the mean  S.D. , p 
0.05 versus controls after 96 h of incubation (ANOVA followed by a post
hoc Dunnett’s t test).











fmk. The percentages of apoptosis are shown in Fig. 12A. The
caspase-8 inhibitor caused a concentration-dependent reduc-
tion of ofloxacin-induced apoptosis, which was more marked
at the concentration of 60 M. Ofloxacin-stimulated apopto-
sis increased by approximately 9.5-fold in the absence of
these inhibitors but did not significantly increase in the
presence of z-IETD-fmk (60 M). It is noteworthy that the
effects of caspase-8 inhibitor were specific because the vehi-
cle dimethyl sulfoxide, used at a similar concentration, had
no effect on ofloxacin-stimulated apoptosis. These results
indicated that ofloxacin-induced apoptosis was dependent on
caspase-8 activation. In addition, we also investigated the
effect of caspase-8 inhibition on ofloxacin-stimulated 1-inte-
grin expression. As shown in Fig. 12B, 1-integrin markedly
declined within 48 h of ofloxacin treatment in the presence of
z-IETD-fmk (60 M), which was similar to the expression
mode of 1-integrin in the presence or absence of z-DEVD-
fmk. This suggested that the loss of 1-integrin was not a
direct consequence of caspase-8 activation. Thus, ofloxacin
stimulated the activation of caspase-8, inhibited 1-integrin
expression and function, and caused apoptosis in chondro-
cytes after treatment of 48 h.
Discussion
In the present study, we set out to investigate the possible
mechanisms of chondrotoxicity of QNs using the popular
drug ofloxacin. An in vitro approach for these studies was
used because literally nothing is known about the mecha-
nism of action of these pharmaceuticals and an in vivo assay
needs at least some basic mechanistic background. Still, the
microencapsulation of isolated chondrocytes allowed us to
maintain an almost in vivo like phenotype of the cells for a
long time in cell culture compared with monolayer grown
Fig. 9. Effects of ofloxacin on Grb2 adaptor (A) and phosphorylated
ERK1/2 protein (B) expression. Cells were treated with 10 g/ml ofloxacin
for up to 96 h as indicated. An antibody against Grb2 adaptor, phospho-
ERK1/2, and total-ERK1/2 was used for detection of the protein by West-
ern blot, respectively, as described under Materials and Methods. The
results of three experiments are shown; bars represent the mean  S.D.
, p  0.05 versus controls after 96 h of incubation (ANOVA followed by
a post hoc Dunnett’s t test).
Fig. 10. Effects of ofloxacin on phosphorylated ERK1/2 (A) and 1-inte-
grin (B) expression in the presence of specific caspase-3 inhibitor z-
DEVD-fmk. Cells were treated with 10 g/ml ofloxacin for up to 96 h after
pretreatment with 4 M z-DEVD-fmk for 1 h. The antibodies against
phospho-ERK1/2, total-ERK1/2, and 1-integrin were used for detection
of the protein by Western blot, as described under Materials and Meth-
ods. The results of three experiments are shown; bars represent the
mean  S.D. , p  0.05 versus controls after 96 h of incubation (ANOVA
followed by a post hoc Dunnett’s t test).











chondrocytes and allowed us to use therapeutically relevant
concentrations of the compound. Using the microencapsu-
lated culture of juvenile rabbit joint chondrocytes, we have
shown that ofloxacin primarily causes apoptosis-mediated
cell death in a concentration-dependent manner, a fact not
previously reported. We also demonstrated that caspase-3 is
involved in ofloxacin-induced apoptotic response of microen-
capsulated chondrocytes. In addition, we also observed that
ofloxacin-induced apoptosis of chondrocytes is associated
with alteration of 1-integrin functions, inhibition on ERK/
MAPK signaling pathway, and activation of caspase-8 after
exposure of cells to 10 g/ml ofloxacin for 48 h. Based on our
current results, we speculate that ofloxacin-induced apopto-
sis in chondrocytes results from 1-integrin disturbance,
which is possibly due to alteration of conformational alterna-
tion of the extracellular domain in 1-integrin. Together with
previous reports, our current data add further evidence to the
hypothesis that a change of integrin function is the primary
event causing subsequent changes in the ERK/MAPK signal-
ing pathway, resulting in caspase-8-dependent apoptosis.
Herein, some of our observations are unique, and some oth-
ers corroborate previous studies. We will highlight the out-
comes of our study and compare and contrast these with
previous studies.
Accumulating evidence has shown that chondrocytes cul-
tured in monolayer in vitro show decreased gene expression
of cartilage-specific proteins, such as type II collagen and
aggrecan, and quickly dedifferentiate to a more fibroblastic
phenotype (van Susante et al., 1995; Enobakhare et al.,
1996). In contrast, chondrocytes cultured in alginate gels
maintain their differentiated phenotype (round shape) and
produce more proteoglycans and type II collagen (van Sus-
ante et al., 1995). Our current results are consistent with the
above findings. Furthermore, our study reveals that viability
of microencapsulated chondrocyte is easily influenced by
ofloxacin compared with that cultured in monolayer. In ad-
dition, a great advantage of the alginate culture system is
that cells can be easily isolated by dissolving the gel matrix
by chelating compounds, e.g., EDTA or phosphates, thus
Fig. 11. Effects of MAPK kinase 1/2 inhibitor U0126 on apoptosis and
1-integrin expression. Cells were incubated with the increasing concen-
trations of U0126. Apoptosis was assessed by fluorescent staining assay
(A), and an antibody against 1-chain of integrins was used for detection
of the protein expression levels by Western blot (B), as described under
Materials and Methods. The results of three experiments are shown; bars
represent the mean  S.D. , p  0.05 versus controls after 96 h of
incubation (ANOVA followed by a post hoc Dunnett’s t test).
Fig. 12. Apoptosis induced by ofloxacin involves the activation of
caspase-8 in microencapsulated chondrocytes. A, cells were exposed to
increasing concentrations (0–60 M) of caspase-8 inhibitor z-IETD-fmk
for 4 h. Ofloxacin (10 g/ml) was then added, and the cells were incubated
for an additional 96 h. The percentage of apoptotic cells was determined
by fluorescent staining, as described under Materials and Methods. The
values are means  S.D. of three independent experiments. #, p  0.05
versus untreated group and , p  0.05 versus group of 10 g/ml ofloxacin
alone. B, likewise, cells were treated with 10 g/ml ofloxacin for up to 96 h
after the pretreatment of 60 M z-DEVD-fmk for 4 h. The antibody
against 1-integrin was used for detection of the protein by Western blot,
as described under Materials and Methods. The results of three experi-
ments are shown; bars represent the mean  S.D. , p  0.05 versus
controls after 96 h of incubation (ANOVA followed by a post hoc Dunnett’s
t test).











allowing further investigations of isolated chondrocytes
(Häuselmann et al., 1992). In articular cartilage, chondro-
cytes receive ECM signals through many receptors, including
the hyaluronic acid receptor CD44, annexin V, and integrins
(Kurtis et al., 2001). For alginate, however, there is no spe-
cific interaction between mammalian cells and the polysac-
charide. Furthermore, alginate carries a negative charge bal-
ance, such that proteins are not readily adsorbed, due to
electrostatic repulsion (Rowley et al., 1999). Thus, we used
alginate-microencapsulated chondrocyte to further study the
chondrotoxicity of ofloxacin.
We find that ofloxacin-induced cell death in microencapsu-
lated chondrocytes is ascribed to the occurrence of apoptosis,
rather than necrosis, which had not been previously re-
ported. The viable fractions of microencapsulated chondro-
cytes exposed to 10 g/ml ofloxacin for 72 and 96 h (Fig. 2B)
corresponded well to the fractions of dead, apoptotic, and
necrotic cells (Fig. 3) determined by fluorescent dye staining.
Given the fact that membrane integrity is lost only very late
in apoptosis, our data demonstrate that the correlation
among apoptotic, dead, and necrotic cells is best obtained by
comparing these parameters in the same cell population,
thus eliminating the suppressive effects of ofloxacin on cell
proliferation.
Proteases of the caspase family are the most important
components of apoptotic pathway, and caspase-3 synthesized
as an inactive precursor is an early marker and an irrevers-
ible point in the progression of apoptosis. Our study showed
that activated caspase-3 was involved in ofloxacin-induced
apoptotic response of microencapsulated chondrocytes. We
also observed the formation of DNA ladder, which is the
typical feature of cell apoptosis, and proteolysis of PARP from
116 to 85 kDa, the symbol of caspase activation in the mi-
croencapsulated chondrocytes exposed to ofloxacin. These re-
sults further confirmed the cell apoptosis-inducing effect of
ofloxacin.
It has been shown that QNs seem to disrupt the cation-
dependent function of 1-integrin due to its characteristics of
Mg2 chelation (Lomaestro and Bailie, 1991). However, this
disruption of function can also affect the integrin-stimulated
signaling transduction pathways (Shakibaei et al., 1993). Of
special interest is the ERK/MAPK signaling pathway. For
this ubiquitous signaling pathway, previous studies with hu-
man chondrocytes have shown that its activation is stimu-
lated via 1-integrin, and subsequent activation of Grb2 and
ERK1/2 in ERK/MAPK signaling pathway is extremely im-
portant for cell differentiation and survival, inhibition of
which can induce apoptosis (Shakibaei et al., 1999, 2001).
Our current data have shown that expression of 1-inte-
grin mRNA does not change; however, 1-integrin receptor
protein decreased significantly over a 96-h period in ofloxa-
cin-treated microencapsulated chondrocytes. Previous inves-
tigations have also shown the alterations of integrin expres-
sion of chondrocytes in immature joint cartilage from rats
after QNs treatment or after feeding a magnesium-deficient
diet (Förster et al., 1996). However, we have found that
tyrosine phosphorylation of intracellular integrin-dependent
signaling proteins was not present in chondrocytes treated
with ofloxacin for 48 h when the expression of 1-integrin
protein significantly declined. Furthermore, supplement of
magnesium also makes the expression of 1-integrin protein,
and occurrence of apoptosis remains unchanged under the
same time points and concentrations of ofloxacin. Because
integrin transition from a low- to high-affinity ligand-binding
state may be a direct consequence of conformational changes,
involving no change in surface density of integrin (Sanchez-
Mateos P et al., 1996). These findings indicate that the 1-
integrin receptors no longer react with the antibody, because
the epitope for the antibody is probably changed or deleted
from some 1-integrin molecules. Thus, it is presumed that
the absence of functional Mg2 leads to conformational
changes of integrin receptor and then perturbs its regular
functions after exposure of 48 h to ofloxacin.
For the ERK/MAPK signaling pathway, expression mode of
its signaling protein Grb2 and phospho-ERK1/2 corresponds
to that of 1-integrin after ofloxacin treatment. However,
inhibition on ofloxacin-induced apoptosis does not affect
phospho-ERK1/2 and 1-integrin expression mode as shown
in that treated by ofloxacin alone. In addition, inhibition of
ERK/MAPK signaling pathway stimulates the apoptosis of
microencapsulated chondrocytes in a concentration-depen-
dent manner, whereas the 1-integrin levels exhibit no
changes under the same conditions. These results further
suggest that changes of 1-integrin expression can inactivate
the ERK/MAPK signaling pathway, resulting in apoptosis.
Stupack et al. (2001) have suggested that “integrin-medi-
ated death” is induced by the cytoplasmic domain of unli-
gated 1-integrin, resulting in the recruitment of caspase-8 to
the cell membrane, where it becomes activated in a death
receptor-independent manner. In the present study, our ob-
servation has indicated that ofloxacin-induced apoptosis in-
volves the caspase-8 activation and that the loss of 1-inte-
grin is not a direct consequence of caspase-8 activation.
Therefore, it is speculated that 1-integrin cannot ligate to
the corresponding ligand because its regular function is per-
turbed by ofloxacin-stimulated conformational changes,
which lead to accumulation of unligated 1-integrin, subse-
quent recruitment of caspase-8, inactivation of ERK/MAPK
signaling pathway, and ultimate occurrence of apoptosis af-
ter the treatment of 48 h.
The reported therapeutic plasma levels of ofloxacin
achieved in cartilage of patients are 4 to 10 g/ml (Hooper
and Wolfson, 1985). In our study, the concentrations (5–10
g/ml) that induce apoptosis in microencapsulated chondro-
cytes are therefore similar to those reached in the plasma of
patients. However, constant concentrations are utilized to act
on the cells continuously under our in vitro experimental
conditions, whereas concentrations in vivo fluctuate over
time.
In summary, the requirement of magnesium for both the
desired antibacterial action and the toxic effect on cartilage
could explain why all QNs known so far possess the potential
for cartilage toxicity. Because ofloxacin, a typical QNs, mark-
edly causes caspase-8-dependent apoptosis of chondrocytes
by affecting the levels of 1-integrin receptor and ERK/
MAPK signaling pathway after exposure to the concentra-
tions similar to those of patient’s plasma at 48 h, it is likely
that other QNs-induced chondrotoxicities involve the same
mechanism(s) as ofloxacin. The apoptosis possibly plays an
important role in QNs-induced arthropathy, although the
question about the detailed mechanism(s) requires further
investigation, e.g., the exact relationship between production
of cellular H2O2, alteration of 1-integrin function, and
caspase-8 activation in the early phase of ofloxacin-induced











chondrotoxicity (12–48 h), since the previous data indicated
that ofloxacin-induced arthropathy seems to correspond to an
early and fairly specific stimulatory effect on the production
of H2O2 by immature articular chondrocytes (Thuong-Guyot
et al., 1994). However, the present evidence of ofloxacin-
induced apoptosis in microencapsulated chondrocyte is im-
portant for exploring new approaches during preclinical
development and clinical risk evaluation of QNs or for strat-
egies to prevent this unusual adverse effect associated with
these valuable antimicrobials.
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